1
|
Choudhary N, Bawari S, Burcher JT, Sinha D, Tewari D, Bishayee A. Targeting Cell Signaling Pathways in Lung Cancer by Bioactive Phytocompounds. Cancers (Basel) 2023; 15:3980. [PMID: 37568796 PMCID: PMC10417502 DOI: 10.3390/cancers15153980] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2023] [Revised: 07/29/2023] [Accepted: 07/31/2023] [Indexed: 08/13/2023] Open
Abstract
Lung cancer is a heterogeneous group of malignancies with high incidence worldwide. It is the most frequently occurring cancer in men and the second most common in women. Due to its frequent diagnosis and variable response to treatment, lung cancer was reported as the top cause of cancer-related deaths worldwide in 2020. Many aberrant signaling cascades are implicated in the pathogenesis of lung cancer, including those involved in apoptosis (B cell lymphoma protein, Bcl-2-associated X protein, first apoptosis signal ligand), growth inhibition (tumor suppressor protein or gene and serine/threonine kinase 11), and growth promotion (epidermal growth factor receptor/proto-oncogenes/phosphatidylinositol-3 kinase). Accordingly, these pathways and their signaling molecules have become promising targets for chemopreventive and chemotherapeutic agents. Recent research provides compelling evidence for the use of plant-based compounds, known collectively as phytochemicals, as anticancer agents. This review discusses major contributing signaling pathways involved in the pathophysiology of lung cancer, as well as currently available treatments and prospective drug candidates. The anticancer potential of naturally occurring bioactive compounds in the context of lung cancer is also discussed, with critical analysis of their mechanistic actions presented by preclinical and clinical studies.
Collapse
Affiliation(s)
- Neeraj Choudhary
- Department of Pharmacognosy, GNA School of Pharmacy, GNA University, Phagwara 144 401, India
| | - Sweta Bawari
- Amity Institute of Pharmacy, Amity University, Noida 201 301, India
| | - Jack T. Burcher
- College of Osteopathic Medicine, Lake Erie College of Osteopathic Medicine, Bradenton, FL 34211, USA
| | - Dona Sinha
- Department of Receptor Biology and Tumor Metastasis, Chittaranjan National Cancer Institute, Kolkata 700 026, India
| | - Devesh Tewari
- Department of Pharmacognosy and Phytochemistry, School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research University, New Delhi 110 017, India
| | - Anupam Bishayee
- College of Osteopathic Medicine, Lake Erie College of Osteopathic Medicine, Bradenton, FL 34211, USA
| |
Collapse
|
2
|
Gupta N, Qayum A, Singh S, Mujwar S, Sangwan PL. Isolation, Cytotoxicity Evaluation, Docking, ADMET and Drug Likeness Studies of Secondary Metabolites from the Stem Bark of
Anthocephalus cadamba
(Roxb.). ChemistrySelect 2022. [DOI: 10.1002/slct.202202950] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
- Nidhi Gupta
- Natural Product and Medicinal Chemistry (NPMC) Division CSIR-Indian Institute of Integrative Medicine Jammu 180001 India
- Department of Pharmaceutical Chemistry M. M. College of Pharmacy Maharishi Markandeshwar (Deemed to be University) Mullana Ambala Haryana India 133207
| | - Arem Qayum
- Cancer Pharmacology Division CSIR-Indian Institute of Integrative Medicine Jammu 180001 India
| | - Shashank Singh
- Cancer Pharmacology Division CSIR-Indian Institute of Integrative Medicine Jammu 180001 India
| | - Somdutt Mujwar
- Chitkara College of Pharmacy Chitkara University, Rajpura Punjab India 140401
| | - Payare L. Sangwan
- Natural Product and Medicinal Chemistry (NPMC) Division CSIR-Indian Institute of Integrative Medicine Jammu 180001 India
| |
Collapse
|
3
|
He J, Yao Y, Liu M, Liao G, Yang X, Lu R. Two New C
21
Steroids from
Gymnema tingens. ChemistrySelect 2022. [DOI: 10.1002/slct.202202726] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Jin‐Hua He
- School of Pharmaceutical Sciences Guangxi University of Chinese Medicine Nanning 530200 China
| | - Yu‐Di Yao
- School of Pharmaceutical Sciences South-Central Minzu University Wuhan 430074 China
| | - Mei‐Yu Liu
- School of Pharmaceutical Sciences Guangxi University of Chinese Medicine Nanning 530200 China
| | - Guang‐Feng Liao
- School of Pharmaceutical Sciences Guangxi University of Chinese Medicine Nanning 530200 China
| | - Xin‐Zhou Yang
- School of Pharmaceutical Sciences Guangxi University of Chinese Medicine Nanning 530200 China
- School of Pharmaceutical Sciences South-Central Minzu University Wuhan 430074 China
| | - Ru‐Mei Lu
- School of Pharmaceutical Sciences Guangxi University of Chinese Medicine Nanning 530200 China
| |
Collapse
|
4
|
Comert Onder F, Siyah P, Durdagi S, Ay M, Ozpolat B. Novel etodolac derivatives as eukaryotic elongation factor 2 kinase (eEF2K) inhibitors for targeted cancer therapy. RSC Med Chem 2022; 13:840-849. [PMID: 35923718 PMCID: PMC9298183 DOI: 10.1039/d2md00105e] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2022] [Accepted: 05/25/2022] [Indexed: 09/17/2023] Open
Abstract
Eukaryotic elongation factor 2 kinase (eEF2K) has been shown to be an important molecular driver of tumorigenesis and validated as a potential novel molecular target in various solid cancers including triple negative breast cancer (TNBC). Therefore, there has been significant interest in identifying novel inhibitors of eEF2K for the development of targeted therapeutics and clinical translation. Herein, we investigated the effects of indole ring containing derivatives of etodolac, a nonsteroidal anti-inflammatory (NSAID) drug, as potential eEF2K inhibitors and we designed and synthesized seven novel compounds with a pyrano[3,4-b] indole core structure. We evaluated the eEF2K inhibitory activity of seven of these novel compounds using in silico molecular modeling and in vitro studies in TNBC cell lines. We identified two novel compounds (EC1 and EC7) with significant in vitro activity in inhibiting eEF2K in TNBC cells. In conclusion, our studies indicate that pyrano[3,4-b] indole scaffold containing compounds demonstrate marked eEF2K inhibitory activity and they may be used as eEF2K inhibitors for the development of eEF2K-targeted therapeutics.
Collapse
Affiliation(s)
- Ferah Comert Onder
- Department of Medical Biology, Çanakkale Onsekiz Mart University, Faculty of Medicine 17020 Çanakkale Turkey
- Department of Experimental Therapeutics, The University of Texas, MD Anderson Cancer Center 1515 Holcombe Boulevard, Unit 422 Houston TX 77030 USA
- Department of Chemistry, Natural Products and Drug Research Laboratory, Çanakkale Onsekiz Mart University, Faculty of Science and Arts 17020 Çanakkale Turkey
| | - Pinar Siyah
- Computational Biology and Molecular Simulations Laboratory, Department of Biophysics, School of Medicine, Bahcesehir University 34734 Istanbul Turkey
| | - Serdar Durdagi
- Computational Biology and Molecular Simulations Laboratory, Department of Biophysics, School of Medicine, Bahcesehir University 34734 Istanbul Turkey
| | - Mehmet Ay
- Department of Chemistry, Natural Products and Drug Research Laboratory, Çanakkale Onsekiz Mart University, Faculty of Science and Arts 17020 Çanakkale Turkey
| | - Bulent Ozpolat
- Department of Experimental Therapeutics, The University of Texas, MD Anderson Cancer Center 1515 Holcombe Boulevard, Unit 422 Houston TX 77030 USA
- Center for RNA Interference and Non-Coding RNAs, The University of Texas, MD Anderson Cancer Center Houston TX USA
| |
Collapse
|
5
|
Secondary metabolites of Anthocephalus chinensis (Lamk.): a concise review. MONATSHEFTE FUR CHEMIE 2021. [DOI: 10.1007/s00706-021-02871-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
6
|
Wang X, Li LL, Xiao Y, Chen XY, Chen JH, Hu XS. A complete sequence of mitochondrial genome of Neolamarckia cadamba and its use for systematic analysis. Sci Rep 2021; 11:21452. [PMID: 34728739 PMCID: PMC8564537 DOI: 10.1038/s41598-021-01040-9] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2021] [Accepted: 10/22/2021] [Indexed: 11/09/2022] Open
Abstract
Neolamarckia cadamba is an important tropical and subtropical tree for timber industry in southern China and is also a medicinal plant because of the secondary product cadambine. N. cadamba belongs to Rubiaceae family and its taxonomic relationships with other species are not fully evaluated based on genome sequences. Here, we report the complete sequences of mitochondrial genome of N. cadamba, which is 414,980 bp in length and successfully assembled in two genome circles (109,836 bp and 305,144 bp). The mtDNA harbors 83 genes in total, including 40 protein-coding genes (PCGs), 31 transfer RNA genes, 6 ribosomal RNA genes, and 6 other genes. The base composition of the whole genome is estimated as 27.26% for base A, 22.63% for C, 22.53% for G, and 27.56% for T, with the A + T content of 54.82% (54.45% in the small circle and 54.79% in the large circle). Repetitive sequences account for ~ 0.14% of the whole genome. A maximum likelihood (ML) tree based on DNA sequences of 24 PCGs supports that N. cadamba belongs to order Gentianales. A ML tree based on rps3 gene of 60 species in family Rubiaceae shows that N. cadamba is more related to Cephalanthus accidentalis and Hymenodictyon parvifolium and belongs to the Cinchonoideae subfamily. The result indicates that N. cadamba is genetically distant from the species and genera of Rubiaceae in systematic position. As the first sequence of mitochondrial genome of N. cadamba, it will provide a useful resource to investigate genetic variation and develop molecular markers for genetic breeding in the future.
Collapse
Affiliation(s)
- Xi Wang
- College of Forestry and Landscape Architecture, South China Agricultural University, Guangdong, 510642, China.,Guangdong Key Laboratory for Innovative Development and Utilization of Forest Plant Germplasm, South China Agricultural University, Guangdong, 510642, China
| | - Ling-Ling Li
- College of Forestry and Landscape Architecture, South China Agricultural University, Guangdong, 510642, China.,Guangdong Key Laboratory for Innovative Development and Utilization of Forest Plant Germplasm, South China Agricultural University, Guangdong, 510642, China
| | - Yu Xiao
- College of Forestry and Landscape Architecture, South China Agricultural University, Guangdong, 510642, China.,Guangdong Key Laboratory for Innovative Development and Utilization of Forest Plant Germplasm, South China Agricultural University, Guangdong, 510642, China
| | - Xiao-Yang Chen
- College of Forestry and Landscape Architecture, South China Agricultural University, Guangdong, 510642, China.,Guangdong Key Laboratory for Innovative Development and Utilization of Forest Plant Germplasm, South China Agricultural University, Guangdong, 510642, China
| | - Jie-Hu Chen
- Science Corporation of Gene (SCGene), Guangzhou, 510000, China
| | - Xin-Sheng Hu
- College of Forestry and Landscape Architecture, South China Agricultural University, Guangdong, 510642, China. .,Guangdong Key Laboratory for Innovative Development and Utilization of Forest Plant Germplasm, South China Agricultural University, Guangdong, 510642, China.
| |
Collapse
|
7
|
Mitra S, Prova SR, Sultana SA, Das R, Nainu F, Emran TB, Tareq AM, Uddin MS, Alqahtani AM, Dhama K, Simal-Gandara J. Therapeutic potential of indole alkaloids in respiratory diseases: A comprehensive review. PHYTOMEDICINE : INTERNATIONAL JOURNAL OF PHYTOTHERAPY AND PHYTOPHARMACOLOGY 2021; 90:153649. [PMID: 34325978 DOI: 10.1016/j.phymed.2021.153649] [Citation(s) in RCA: 21] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/29/2021] [Accepted: 07/01/2021] [Indexed: 06/13/2023]
Abstract
BACKGROUND Indole alkaloids are very promising for potential therapeutic purposes and appear to be particularly effective against respiratory diseases. Several experimental studies have been performed, both in vivo and in vitro, to evaluate the effectiveness of indole alkaloids for the management of respiratory disorders, including asthma, emphysema, tuberculosis, cancer, and pulmonary fibrosis. PURPOSE The fundamental objective of this review was to summarize the in-depth therapeutic potential of indole alkaloids against various respiratory disorders. STUDY DESIGN In addition to describing the therapeutic potential, this review also evaluates the toxicity of these alkaloids, which have been utilized for therapeutic benefits but have demonstrated toxic consequences. Some indole alkaloids, including scholaricine, 19-epischolaricine, vallesamine, and picrinine, which are derived from the plant Alstonia scholaris, have shown toxic effects in non-rodent models. METHODS This review also discusses clinical studies exploring the therapeutic efficacy of indole alkaloids, which have confirmed the promising benefits observed in vivo and in vitro. RESULTS The indole alkaloidal compounds have shown efficacy in subjects with respiratory diseases. CONCLUSION The available data established both preclinical and clinical studies confirm the potential of indole alkaloids to treat the respiratory disorders.
Collapse
Affiliation(s)
- Saikat Mitra
- Department of Pharmacy, Faculty of Pharmacy, University of Dhaka, Dhaka 1000, Bangladesh
| | - Shajuthi Rahman Prova
- Department of Pharmacy, Faculty of Pharmacy, University of Dhaka, Dhaka 1000, Bangladesh
| | - Sifat Ara Sultana
- Department of Pharmacy, Faculty of Pharmacy, University of Dhaka, Dhaka 1000, Bangladesh
| | - Rajib Das
- Department of Pharmacy, Faculty of Pharmacy, University of Dhaka, Dhaka 1000, Bangladesh
| | - Firzan Nainu
- Faculty of Pharmacy, Hasanuddin University, Makassar, South Sulawesi 90245, Indonesia
| | - Talha Bin Emran
- Department of Pharmacy, BGC Trust University Bangladesh, Chittagong 4381, Bangladesh.
| | - Abu Montakim Tareq
- Department of Pharmacy, International Islamic University Chittagong, Chittagong 4318, Bangladesh
| | - Md Sahab Uddin
- Department of Pharmacy, Southeast University, Dhaka 1213, Bangladesh; Pharmakon Neuroscience Research Network, Dhaka 1207, Bangladesh
| | - Ali M Alqahtani
- Department of Pharmacology, College of Pharmacy, King Khalid University, Abha 62529, Saudi Arabia
| | - Kuldeep Dhama
- Division of Pathology, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly 243122, Uttar Pradesh, India
| | - Jesus Simal-Gandara
- Nutrition and Bromatology Group, Department of Analytical and Food Chemistry, Faculty of Food Science and Technology, University of Vigo - Ourense Campus, E32004 Ourense, Spain.
| |
Collapse
|
8
|
Omar F, Tareq AM, Alqahtani AM, Dhama K, Sayeed MA, Emran TB, Simal-Gandara J. Plant-Based Indole Alkaloids: A Comprehensive Overview from a Pharmacological Perspective. Molecules 2021; 26:molecules26082297. [PMID: 33921093 PMCID: PMC8071433 DOI: 10.3390/molecules26082297] [Citation(s) in RCA: 46] [Impact Index Per Article: 15.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2021] [Revised: 04/09/2021] [Accepted: 04/12/2021] [Indexed: 12/12/2022] Open
Abstract
Plant-based indole alkaloids are very rich in pharmacological activities, and the indole nucleus is considered to contribute greatly to these activities. This review's fundamental objective is to summarize the pharmacological potential of indole alkaloids that have been derived from plants and provide a detailed evaluation of their established pharmacological activities, which may contribute to identifying new lead compounds. The study was performed by searching various scientific databases, including Springer, Elsevier, ACS Publications, Taylor and Francis, Thieme, Wiley Online Library, ProQuest, MDPI, and online scientific books. A total of 100 indole compounds were identified and reviewed. The most active compounds possessed a variety of pharmacological activities, including anticancer, antibacterial, antiviral, antimalarial, antifungal, anti-inflammatory, antidepressant, analgesic, hypotensive, anticholinesterase, antiplatelet, antidiarrheal, spasmolytic, antileishmanial, lipid-lowering, antimycobacterial, and antidiabetic activities. Although some compounds have potent activity, some only have mild-to-moderate activity. The pharmacokinetic profiles of some of the identified compounds, such as brucine, mitragynine, 7-hydroxymitragynine, vindoline, and harmane, were also reviewed. Most of these compounds showed promising pharmacological activity. An in-depth pharmacological evaluation of these compounds should be performed to determine whether any of these indoles may serve as new leads.
Collapse
Affiliation(s)
- Faisal Omar
- Department of Pharmacy, International Islamic University Chittagong, Chittagong 4318, Bangladesh; (F.O.); (A.M.T.)
| | - Abu Montakim Tareq
- Department of Pharmacy, International Islamic University Chittagong, Chittagong 4318, Bangladesh; (F.O.); (A.M.T.)
| | - Ali M. Alqahtani
- Department of Pharmacology, College of Pharmacy, King Khalid University, Abha 62529, Saudi Arabia;
| | - Kuldeep Dhama
- Division of Pathology, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly 243122, Uttar Pradesh, India;
| | - Mohammed Abu Sayeed
- Department of Pharmacy, International Islamic University Chittagong, Chittagong 4318, Bangladesh; (F.O.); (A.M.T.)
- Correspondence: (M.A.S.); (T.B.E.); (J.S.-G.); Tel.: +88-0-167-041-9435 (M.A.S.); +88-0-181-994-2214 (T.B.E.); +34-988-387000 (J.S.-G.)
| | - Talha Bin Emran
- Department of Pharmacy, BGC Trust University Bangladesh, Chittagong 4381, Bangladesh
- Correspondence: (M.A.S.); (T.B.E.); (J.S.-G.); Tel.: +88-0-167-041-9435 (M.A.S.); +88-0-181-994-2214 (T.B.E.); +34-988-387000 (J.S.-G.)
| | - Jesus Simal-Gandara
- Nutrition and Bromatology Group, Department of Analytical and Food Chemistry, Faculty of Food Science and Technology, University of Vigo—Ourense Campus, E32004 Ourense, Spain
- Correspondence: (M.A.S.); (T.B.E.); (J.S.-G.); Tel.: +88-0-167-041-9435 (M.A.S.); +88-0-181-994-2214 (T.B.E.); +34-988-387000 (J.S.-G.)
| |
Collapse
|
9
|
Sakamoto J, Umeda Y, Rakumitsu K, Sumimoto M, Ishikawa H. Total Syntheses of (−)‐Strictosidine and Related Indole Alkaloid Glycosides. Angew Chem Int Ed Engl 2020; 59:13414-13422. [DOI: 10.1002/anie.202005748] [Citation(s) in RCA: 19] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2020] [Indexed: 12/26/2022]
Affiliation(s)
- Jukiya Sakamoto
- Department of Chemistry Graduate School of Science and Technology Kumamoto University 2-39-1, Kurokami, Chuo-ku Kumamoto 860-8555 Japan
| | - Yuhei Umeda
- Department of Chemistry Graduate School of Science and Technology Kumamoto University 2-39-1, Kurokami, Chuo-ku Kumamoto 860-8555 Japan
| | - Kenta Rakumitsu
- Department of Chemistry Graduate School of Science and Technology Kumamoto University 2-39-1, Kurokami, Chuo-ku Kumamoto 860-8555 Japan
| | - Michinori Sumimoto
- Graduate School of Sciences and Technology for Innovation Yamaguchi University 2-16-1, Tokiwadai Ube Yamaguchi 755-8611 Japan
| | - Hayato Ishikawa
- Department of Chemistry Graduate School of Science and Technology Kumamoto University 2-39-1, Kurokami, Chuo-ku Kumamoto 860-8555 Japan
- Faculty of Advanced Science and Technology Kumamoto University 2-39-1, Kurokami, Chuo-ku Kumamoto 860-8555 Japan
| |
Collapse
|
10
|
Sakamoto J, Umeda Y, Rakumitsu K, Sumimoto M, Ishikawa H. Total Syntheses of (−)‐Strictosidine and Related Indole Alkaloid Glycosides. Angew Chem Int Ed Engl 2020. [DOI: 10.1002/ange.202005748] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Affiliation(s)
- Jukiya Sakamoto
- Department of Chemistry Graduate School of Science and Technology Kumamoto University 2-39-1, Kurokami, Chuo-ku Kumamoto 860-8555 Japan
| | - Yuhei Umeda
- Department of Chemistry Graduate School of Science and Technology Kumamoto University 2-39-1, Kurokami, Chuo-ku Kumamoto 860-8555 Japan
| | - Kenta Rakumitsu
- Department of Chemistry Graduate School of Science and Technology Kumamoto University 2-39-1, Kurokami, Chuo-ku Kumamoto 860-8555 Japan
| | - Michinori Sumimoto
- Graduate School of Sciences and Technology for Innovation Yamaguchi University 2-16-1, Tokiwadai Ube Yamaguchi 755-8611 Japan
| | - Hayato Ishikawa
- Department of Chemistry Graduate School of Science and Technology Kumamoto University 2-39-1, Kurokami, Chuo-ku Kumamoto 860-8555 Japan
- Faculty of Advanced Science and Technology Kumamoto University 2-39-1, Kurokami, Chuo-ku Kumamoto 860-8555 Japan
| |
Collapse
|
11
|
Mishra AK, Tewari SP. Density functional theory calculations of spectral, NLO, reactivity, NBO properties and docking study of Vincosamide-N-Oxide active against lung cancer cell lines H1299. SN APPLIED SCIENCES 2020. [DOI: 10.1007/s42452-020-2842-9] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
12
|
Dhuguru J, Skouta R. Role of Indole Scaffolds as Pharmacophores in the Development of Anti-Lung Cancer Agents. Molecules 2020; 25:E1615. [PMID: 32244744 PMCID: PMC7181244 DOI: 10.3390/molecules25071615] [Citation(s) in RCA: 60] [Impact Index Per Article: 15.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2020] [Revised: 03/24/2020] [Accepted: 03/30/2020] [Indexed: 12/24/2022] Open
Abstract
Lung cancer is the leading cause of death in men and women worldwide, affecting millions of people. Between the two types of lung cancers, non-small cell lung cancer (NSCLC) is more common than small cell lung cancer (SCLC). Besides surgery and radiotherapy, chemotherapy is the most important method of treatment for lung cancer. Indole scaffold is considered one of the most privileged scaffolds in heterocyclic chemistry. Indole may serve as an effective probe for the development of new drug candidates against challenging diseases, including lung cancer. In this review, we will focus on discussing the existing indole based pharmacophores in the clinical and pre-clinical stages of development against lung cancer, along with the synthesis of some of the selected anti-lung cancer drugs. Moreover, the basic mechanism of action underlying indole based anti-lung cancer treatment, such as protein kinase inhibition, histone deacetylase inhibition, DNA topoisomerase inhibition, and tubulin inhibition will also be discussed.
Collapse
Affiliation(s)
| | - Rachid Skouta
- Department of Biology, University of Massachusetts, Amherst, MA 01003, USA;
| |
Collapse
|
13
|
Khan MA, Ahamad T, Saquib M, Hussain MK, Khan MF. Unmodified household coffee maker assisted extraction and purification of anticancer agents from Dillenia indica fruits. Nat Prod Res 2019; 35:984-987. [PMID: 31134812 DOI: 10.1080/14786419.2019.1608546] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
Bioassay targeted, 80% aqueous ethanol crude extract of the fruits of Dillenia indica Linn, using the unmodified household coffee maker, afforded five compounds, namely betulinic acid (1), rhamnazin (2), dillenetin (3), luteolin-7-O-β-D-glucoside (4) and hypolaetin-8-O-β-D-glucoside (5). The crude extract, fractions and purified compounds were tested against MDA MB-231, A549 and HeLa cancer cell lines by MTT assay, using betulinic acid 1, as a positive control. Compound 3 showed the best activity against A549 (IC50 = 26.60 ± 2.5 µM) and HeLa cancer cell lines (IC50 =19.35 ± 0.9 µM), whereas compound 5 was found to show the best activity against MDA MB-231 (IC50 = 34.62 ± 5.2µM) cancer cell line. These highly potent anticancer compounds obtained from the fruits of D. indica may be suitable for herbal drug development and formulations.
Collapse
Affiliation(s)
- Mohsin Ali Khan
- Research Unit, Era's Lucknow Medical College & Hospital, Era University, Lucknow, UP, India
| | - Tanveer Ahamad
- Department of Biotechnology, Era's Lucknow Medical College & Hospital, Era University, Lucknow, UP, India
| | - Mohammad Saquib
- Department of Chemistry, University of Allahabad, Allahabad, UP, India
| | - Mohd Kamil Hussain
- Department of Chemistry, Government Raza Post Graduate College, Rampur, UP, India
| | - Mohammad Faheem Khan
- Department of Biotechnology, Era's Lucknow Medical College & Hospital, Era University, Lucknow, UP, India.,Department of Chemistry, Era University, Lucknow, UP, India
| |
Collapse
|
14
|
Saini M, Khan MF, Sangwan R, Khan MA, Kumar A, Verma R, Ahamad T, Jain S. Design, Synthesis and
In‐Vitro
Antitumor Activity of Lupeol Derivatives
via
Modification at C‐3 and C‐30 Positions. ChemistrySelect 2019. [DOI: 10.1002/slct.201803101] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
Affiliation(s)
- Monika Saini
- Department of ChemistryUniversity of Lucknow Lucknow- 226001, UP India
| | - Mohammad Faheem Khan
- Department of BiotechnologyEra's Lucknow Medical College & HospitalEra University Lucknow- 226003, UP India
| | - Reetu Sangwan
- Department of ChemistryUniversity of Lucknow Lucknow- 226001, UP India
| | - Mohsin Ali Khan
- Department of BiotechnologyEra's Lucknow Medical College & HospitalEra University Lucknow- 226003, UP India
| | - Ashok Kumar
- Department of Chemistry University of Lucknow Lucknow- 226001, UP India
| | - Ruchi Verma
- Department of ChemistryUniversity of Lucknow Lucknow- 226001, UP India
| | - Tanveer Ahamad
- Department of BiotechnologyEra's Lucknow Medical College & HospitalEra University Lucknow- 226003, UP India
| | - Sudha Jain
- Department of ChemistryUniversity of Lucknow Lucknow- 226001, UP India
| |
Collapse
|